# A Study Evaluating the Safety and Efficacy of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis

> **NCT03122860** · PHASE2 · COMPLETED · sponsor: **Biosplice Therapeutics, Inc.** · enrollment: 700 (actual)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** SM04690
- **OTHER:** Placebo
- **OTHER:** Sham

## Key facts

- **NCT ID:** NCT03122860
- **Lead sponsor:** Biosplice Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-24
- **Primary completion:** 2018-04-30
- **Final completion:** 2018-04-30
- **Target enrollment:** 700 (ACTUAL)
- **Last updated:** 2021-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03122860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03122860, "A Study Evaluating the Safety and Efficacy of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03122860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*